SIRT1 and Parkinson disease: Lastly, the miR-34 family target SIRT1 to affect tau metabolism, are decreased in Parkinson's disease patients and show increased expression in the presence of mutant HTT (Wang et al., 2009; Schonrock and Gotz, 2012).